Integrated Molecular and Clinical Profiling to Improve Disease Characterization and Outcome Prediction in Nodal Marginal Zone Lymphoma

Study to Assess Effectiveness and Safety of Zanubrutinib for Patients With Marginal Zone Lymphoma Treated in Italy Under the Named Patient Program (NPP)

NCT06823960 ·Status: RECRUITING

A Prospective, Observational Cohort Study on the Clinical Impact of Novel Monoclonal Antibodies in B-cell Non-Hodgkin Lymphoma in Italian Clinical Practice

NCT06008691 ·Status: RECRUITING

Italian Study of Patients With Lymphoma

NCT06814925 ·Status: RECRUITING

Tumor Heterogeneity in Diffuse Large B-cell Lymphoma in Relation to CNS Involvement and Cell-free DNA

NCT04763148 ·Status: COMPLETED

Translational Study of Molecular Classification of Relapsed/Refractory Diffuse Large B-cell Lymphoma

NCT05318391 ·Status: COMPLETED

Primary Mediastinal Large B-cell Lymphoma (PMBCL): Multicenter Retrospective Study

NCT05162170 ·Status: COMPLETED

Study of Prognostic Factors in Adult Lymphoblastic Lymphoma

NCT03571997 ·Status: UNKNOWN

Immunological Senescence Phenotype as a Resistance Profile to Pembrolizumab in Patients With Relapsed/Refractory Hodgkin's Lymphoma

NCT06733987 ·Status: RECRUITING

Study in Patients With Relapsed/Refractory Primary Mediastinal Lymphoma Treated With Pembrolizumab or Nivolumab in Combination With Brentuximab Vedotin in a Real-life Context

NCT06781450 ·Status: RECRUITING

Primary Mediastinal Large B-cell Lymphoma With CNS Involvement

NCT06024694 ·Status: ACTIVE_NOT_RECRUITING

BCL6-rearrangements Implications in Non-Hodgkin Lymphomas.

NCT06424379 ·Status: ACTIVE_NOT_RECRUITING

Phase Ⅰ Clinical Study of Anti-CD52 Monoclonal Antibody in NHL and T-PLL

NCT05557903 ·Status: UNKNOWN ·Phase: PHASE1

A Cohort Study in Newly Diagnosed MZL

NCT06449885 ·Status: RECRUITING

Study of the Pronostic Impact of Immunohistochemical, Histological and Radiological Factors in Patients With Primary Central Nervous System Lymphoma.

NCT05347511 ·Status: UNKNOWN

Non-invasive Tumor Immunoglobulin Gene Next Generation Sequencing (IgNGS) in Diffuse Large B Cell Lymphoma (DLBCL)

NCT04237168 ·Status: UNKNOWN

Mixed Molecular Clinical Index (MMCI) in Diffuse Large B-cell Lymphoma (DLBCL)

NCT04300101 ·Status: RECRUITING

Identification of Prognostic Factors and New Therapeutic Targets in Cutaneous Lymphomas

NCT04520529 ·Status: NOT_YET_RECRUITING ·Phase: NA

Phase II Study of Chlorambucil and Subcutaneous Rituximab in Patients With Extranodal MALT Lymphoma

NCT01808599 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Observational Study for the Cytofluorimetric Analysis of Cerebrospinal Fluid in Non-Hodgkin's Lymphoma Patients

NCT00949741 ·Status: COMPLETED

Follow Up of High Risk Hodgkin Lymphoma in First Complete Remission

NCT04298619 ·Status: COMPLETED

A Clinico-Pathologic Study of Primary Mediastinal B-Cell Lymphoma

NCT00944567 ·Status: COMPLETED

This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma

NCT07121946 ·Status: RECRUITING ·Phase: PHASE1

Quality Of Life On Elderly Patients With Low Grade Non-Hodgkin Lymphoma

NCT05524298 ·Status: RECRUITING

Obinutuzumab in Combination With Lenalidomide in Relapsed or Refractory Marginal Zone Lymphoma

NCT05846750 ·Status: RECRUITING ·Phase: PHASE2

Clinical Study on Anti-PD-1 Plus Lenalidomide and Azacitidine in Relapsed/Refractory Peripheral T-cell Lymphoma

NCT05182957 ·Status: RECRUITING ·Phase: PHASE2